Literature DB >> 12531334

Induction of immune responses by DNA vaccines in large animals.

L A Babiuk1, R Pontarollo, S Babiuk, B Loehr, S van Drunen Littel-van den Hurk.   

Abstract

It is generally recognized that DNA vaccines are often less effective in large animals than in mice. One possible reason for this reduced effectiveness may be transfection deficiency and the low level of expression elicited by plasmid vectors in large animals. In our attempt to enhance transfection efficiency and, thereby, enhance immune responses, we employed a variety of methods inducing gene gun delivery or suppositories as delivery vehicles to mucosal surfaces, as well as electroporation for systemic immunization. To test these different systems, we used two different antigens-a membrane antigen from bovine herpesvirus glycoprotein (BHV-1) gD and a particulate antigen from hepatitis virus B. Gene gun and suppository delivery of BHV-1 gD to the vagina resulted in the induction of mucosal immunity not only in the vagina, but also at other mucosal surfaces. These data support the contention of a common mucosal immune system. In the case of electroporation, we were able to develop significant enhancement of gene expression following electroporation with surface electrodes (non-invasive electroporation) as well as invasive electroporation using single or six-needle electrodes. Various delivery systems such as bioject or needle delivery also influenced the immune response in both the presence and absence of electroporation. These studies also demonstrated that co-administration of plasmids coding for two different antigens (BHV-1 gD and hepatitis B surface antigen (HbsAg)) did not result in significant interference between the plasmids. These studies suggest that various combinations of delivery systems can enhance immunity to DNA-based vaccines and make them practical for administration of these vaccines in large animals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531334     DOI: 10.1016/s0264-410x(02)00574-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  36 in total

1.  DNA vaccine construct incorporating intercellular trafficking and intracellular targeting motifs effectively primes and induces memory B- and T-cell responses in outbred animals.

Authors:  Waithaka Mwangi; Wendy C Brown; Gary A Splitter; Christopher J Davies; Chris J Howard; Jayne C Hope; Yoko Aida; Yan Zhuang; Beverly J Hunter; Guy H Palmer
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

2.  CCL4 as an adjuvant for DNA vaccination in a Her2/neu mouse tumor model.

Authors:  T Nguyen-Hoai; M Pham-Duc; M Gries; B Dörken; A Pezzutto; J Westermann
Journal:  Cancer Gene Ther       Date:  2016-04-08       Impact factor: 5.987

3.  Comparative functional potency of DNA vaccines encoding Plasmodium falciparum transmission blocking target antigens Pfs48/45 and Pfs25 administered alone or in combination by in vivo electroporation in rhesus macaques.

Authors:  Dibyadyuti Datta; Geetha P Bansal; Brooke Grasperge; Dale S Martin; Mario Philipp; Dietlind Gerloff; Barry Ellefsen; Drew Hannaman; Nirbhay Kumar
Journal:  Vaccine       Date:  2017-11-10       Impact factor: 3.641

4.  Bovine herpesvirus 1 VP22 enhances the efficacy of a DNA vaccine in cattle.

Authors:  Chunfu Zheng; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity.

Authors:  Fumihiko Takeshita; Toshiyuki Tanaka; Tomoko Matsuda; Miyuki Tozuka; Kouji Kobiyama; Sukumar Saha; Kiyohiko Matsui; Ken J Ishii; Cevayir Coban; Shizuo Akira; Norihisa Ishii; Koichi Suzuki; Dennis M Klinman; Kenji Okuda; Shin Sasaki
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.

Authors:  Yeu-Chun Kim; Jae-Min Song; Aleksandr S Lipatov; Seong-O Choi; Jeong Woo Lee; Ruben O Donis; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  Eur J Pharm Biopharm       Date:  2012-04-03       Impact factor: 5.571

Review 7.  Cutaneous immunization: an evolving paradigm in influenza vaccines.

Authors:  Harvinder S Gill; Sang-Moo Kang; Fu-Shi Quan; Richard W Compans
Journal:  Expert Opin Drug Deliv       Date:  2014-02-12       Impact factor: 6.648

Review 8.  Immunogenicity of DNA- and recombinant protein-based Alzheimer disease epitope vaccines.

Authors:  Hayk Davtyan; Andrew Bacon; Irina Petrushina; Karen Zagorski; David H Cribbs; Anahit Ghochikyan; Michael G Agadjanyan
Journal:  Hum Vaccin Immunother       Date:  2014-02-13       Impact factor: 3.452

9.  Modulation of immune responses to bovine herpesvirus-1 in cattle by immunization with a DNA vaccine encoding glycoprotein D as a fusion protein with bovine CD154.

Authors:  Sharmila Manoj; Philip J Griebel; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

10.  DNA prime-protein boost increased the titer, avidity and persistence of anti-Abeta antibodies in wild-type mice.

Authors:  H Davtyan; M Mkrtichyan; N Movsesyan; I Petrushina; G Mamikonyan; D H Cribbs; M G Agadjanyan; A Ghochikyan
Journal:  Gene Ther       Date:  2009-10-29       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.